Dr.Surbhi Kansal, and Mainsha Jain. “IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC ESBL PRODUCING ENTEROBACTERIACEAE”. Journal of Population Therapeutics and Clinical Pharmacology 33, no. 2 (May 10, 2026): 841–852. Accessed October 2, 2026. https://jptcp.com/index.php/jptcp/article/view/13508.